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Background: There is much disagreement about the best method to perform pre-participation screening of elite intercollegiate athletes. Recent 
studies have demonstrated that performing history and physical, electrocardiography (ECG), and echocardiography (TTE) identify additional 
pathology. Previously, we have performed focused screening with TTE, looking at ventricular hypertrophy and valvular abnormalities. Because >85% of 
the abnormalities sought are congenital, we have proposed a more complete congenital TTE.
Methods: Starting July 2010, we screened 185 incoming first year elite NCAA Division I intercollegiate athletes at the University of Virginia utilizing 
a congenital TTE protocol in addition to history and physical exam and ECG. All studies were performed on a laptop-sized TTE machine and read on 
site by an experienced congenital ultrasonographer (RWB).
Results: Utilizing this method, we identified 8 abnormalities, some requiring further follow-up and others possible modification of exercise. We identified 
2 congenital bicuspid aortic valves, one with mild to moderate aortic regurgitation (AR) and one with a functionally normal valve and mild aortopathy, 2 
pulmonic valve stenosis, one with a dilated pulmonary artery, 1 Ebstein’s anomaly, 1 mild non-compaction, 1 left SVC, and 1 patent ductus arteriosus. The 
overall rate of CHD in this population of elite athletes was 4%. None of the findings was identified on physical exam nor by ECG.
Conclusions: The yield of findings using this protocol was much higher than utilizing a standard adult TTE protocol. While some findings do not 
directly impact risk of sudden cardiac death, they do impact long-term follow-up for these athletes. In particular, aortic valve and associated 
aortopathy may require more aggressive follow-up with regular TTE and may impact medication choices in these athletes. The best protocol for 
identifying abnormalities in this population remains to be determined.
